Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Winter

Showing results (671-680 of 715) with videos related to

Pageof 72
Sort By:
Leukemia|February 24, 2018
Flow-cytometric vs. -morphologic assessment of remission in childhood acute lymphoblastic leukemia: a report from the Children's Oncology Group (COG)Sumit Gupta, Meenakshi Devidas, Mignon L Loh, et al.
Science Signaling|December 25, 2014
Systematic identification of signaling pathways with potential to confer anticancer drug resistanceColin A Martz, Kathleen A Ottina, Katherine R Singleton, et al.
Cell Reports|July 27, 2017
A Landscape of Therapeutic Cooperativity in KRAS Mutant Cancers Reveals Principles for Controlling Tumor EvolutionGrace R Anderson, Peter S Winter, Kevin H Lin, et al.
Blood|January 7, 2018
Preclinical efficacy of daratumumab in T-cell acute lymphoblastic leukemiaKaren L Bride, Tiffaney L Vincent, Soo-Yeon Im, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 24, 2018
Improved Survival for Children and Young Adults With T-Lineage Acute Lymphoblastic Leukemia: Results From the Children's Oncology Group AALL0434 Methotrexate RandomizationStuart S Winter, Kimberly P Dunsmore, Meenakshi Devidas, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 20, 2020
Children's Oncology Group AALL0434: A Phase III Randomized Clinical Trial Testing Nelarabine in Newly Diagnosed T-Cell Acute Lymphoblastic LeukemiaKimberly P Dunsmore, Stuart S Winter, Meenakshi Devidas, et al.
Nature Biotechnology|October 7, 2024
Scalable, compressed phenotypic screening using pooled perturbationsNuo Liu, Walaa E Kattan, Benjamin E Mead, et al.
The Journal of Clinical Investigation|December 2, 2014
Metabolic programming and PDHK1 control CD4+ T cell subsets and inflammationValerie A Gerriets, Rigel J Kishton, Amanda G Nichols, et al.
Biorxiv : the Preprint Server for Biology|January 30, 2023
MCB-613 exploits a collateral sensitivity in drug resistant <i>EGFR</i>-mutant non-small cell lung cancer through covalent inhibition of KEAP1Christopher F Bassil, Gray R Anderson, Benjamin Mayro, et al.
The Journal of Molecular Diagnostics : JMD|July 30, 2016
Health Care Infrastructure for Financially Sustainable Clinical GenomicsJochen K Lennerz, Heather M McLaughlin, Jason M Baron, et al.
Pageof 72

Showing results (671-680 of 715) with videos related to

Sort By:
Pageof 72
Leukemia|February 24, 2018
Flow-cytometric vs. -morphologic assessment of remission in childhood acute lymphoblastic leukemia: a report from the Children's Oncology Group (COG)Sumit Gupta, Meenakshi Devidas, Mignon L Loh, et al.
Science Signaling|December 25, 2014
Systematic identification of signaling pathways with potential to confer anticancer drug resistanceColin A Martz, Kathleen A Ottina, Katherine R Singleton, et al.
Cell Reports|July 27, 2017
A Landscape of Therapeutic Cooperativity in KRAS Mutant Cancers Reveals Principles for Controlling Tumor EvolutionGrace R Anderson, Peter S Winter, Kevin H Lin, et al.
Blood|January 7, 2018
Preclinical efficacy of daratumumab in T-cell acute lymphoblastic leukemiaKaren L Bride, Tiffaney L Vincent, Soo-Yeon Im, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 24, 2018
Improved Survival for Children and Young Adults With T-Lineage Acute Lymphoblastic Leukemia: Results From the Children's Oncology Group AALL0434 Methotrexate RandomizationStuart S Winter, Kimberly P Dunsmore, Meenakshi Devidas, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 20, 2020
Children's Oncology Group AALL0434: A Phase III Randomized Clinical Trial Testing Nelarabine in Newly Diagnosed T-Cell Acute Lymphoblastic LeukemiaKimberly P Dunsmore, Stuart S Winter, Meenakshi Devidas, et al.
Nature Biotechnology|October 7, 2024
Scalable, compressed phenotypic screening using pooled perturbationsNuo Liu, Walaa E Kattan, Benjamin E Mead, et al.
The Journal of Clinical Investigation|December 2, 2014
Metabolic programming and PDHK1 control CD4+ T cell subsets and inflammationValerie A Gerriets, Rigel J Kishton, Amanda G Nichols, et al.
Biorxiv : the Preprint Server for Biology|January 30, 2023
MCB-613 exploits a collateral sensitivity in drug resistant <i>EGFR</i>-mutant non-small cell lung cancer through covalent inhibition of KEAP1Christopher F Bassil, Gray R Anderson, Benjamin Mayro, et al.
The Journal of Molecular Diagnostics : JMD|July 30, 2016
Health Care Infrastructure for Financially Sustainable Clinical GenomicsJochen K Lennerz, Heather M McLaughlin, Jason M Baron, et al.
Pageof 72